
Management Change13 Oct 2026, 12:20 pm
Senores Pharma: Re-appoints Swapnil Shah as MD
AI Summary
Senores Pharmaceuticals Ltd announced that its Board of Directors, in a meeting held on October 13, 2026, approved the re-appointment of Mr. Swapnil Jatinbhai Shah as the Managing Director for a period of three years, effective October 15, 2026. This re-appointment is subject to shareholder approval via a postal ballot. The Board also approved the re-appointment of Mr. Chetan Bipinchandra Shah as Whole Time Director for a period of three years, effective November 10, 2026, also subject to shareholder approval. Mr. Swapnil Jatinbhai Shah has over 15 years of experience in the pharmaceutical sector and is a promoter of the company.
Key Highlights
- Board approved re-appointment of Mr. Swapnil Jatinbhai Shah as MD.
- Re-appointment is for three years, effective October 15, 2026.
- Shareholder approval required via postal ballot.
- Board also approved re-appointment of Mr. Chetan Bipinchandra Shah as Whole Time Director.
- Mr. Shah has over 15 years of experience in pharma sector.
Price Impact
More from SENORES